Schizophrenia Research
Volume 118, Issue 1 , Pages 218-223, May 2010

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial

  • Preeta Kaur Narula

      Affiliations

    • Department of Pharmacology, Lady Hardinge Medical College and Associated S.S.K. Hospitals, New Delhi, India
    • Corresponding Author InformationCorresponding author. J – 13/42, Rajouri Garden, New Delhi 110027, India. Tel: +91 9811581034.
    • ,
  • H.S. Rehan

      Affiliations

    • Department of Pharmacology, Lady Hardinge Medical College and Associated S.S.K. Hospitals, New Delhi, India
    • ,
  • K.E.S. Unni

      Affiliations

    • Department of Psychiatry, Lady Hardinge Medical College and Associated S.S.K. Hospitals, New Delhi, India
    • ,
  • Neeraj Gupta

      Affiliations

    • Department of Psychiatry, Lady Hardinge Medical College and Associated S.S.K. Hospitals, New Delhi, India

Received 24 May 2009; received in revised form 29 January 2010; accepted 1 February 2010. published online 08 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-9964(10)00081-2

doi:10.1016/j.schres.2010.02.001

Schizophrenia Research
Volume 118, Issue 1 , Pages 218-223, May 2010

Article Tools